 |
 |
Full Text
DNAzyme technology and cancer therapy: cleave and let die
Dass et al. Mol Cancer Ther.2008;
7:
243-251
|
|
|
|
|
| To view this item, select one of the options below: |
|
|
|
 |
Sign In |
|
|
|
|
|
|
Purchase Short-Term Access |
|
 |
Pay per Article - You may access this article (from the computer you are currently using) for 1 day for US$15.00. |
|
|
SitePass - You may access all content in Molecular Cancer Therapeutics Online (from the computer you are currently using) for 24 hours for US$25.00. |
|
|
|
Regain Access - You can regain access to a recent Pay per Article or SitePass purchase if your access period has not yet expired. |
|
|
|
|
Sign Up |
|
|
Subscribe to the Journal - Subscribe to the print and/or online journal. |
|
|
|
|
